CANNALEAN

CannaLean is an R&D company developing CBD based solutions to benefit millions of patients suffering from Dyslipidemia. The company is committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and Chitosan that will potentially benefit millions of patients suffering from Dyslipidemia. CannaLean's preliminary results show the effect of the formulation of cholesterol and triglyceride reduction. It uses a synthetic form of CBD, a non-psychotropic component of cannabis, with chitosan, a biocompatible, non-toxic, and non-immunogenic compound that enhances the potential of CBD to reduce lipid blood levels. CannaLean was founded in 2017 and is headquartered in Bene Beraq, Israel.

#SimilarOrganizations #People #Website #More

CANNALEAN

Social Links:

Industry:

Biotechnology Cannabis Medical

Founded:

2017-01-01

Address:

Bene Beraq, Tel Aviv, Israel

Country:

Israel

Website Url:

http://www.cannaleanbio.com

Total Employee:

Status:

Active

Contact:

(972) 3 617 6644

Email Addresses:

[email protected]

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Apple Mobile Web Clips Icon WordPress Font Awesome Apache Mobile Non Scaleable Content Sitelinks Search Box